News
Researchers working on an incurable blood cancer can now use a new lab model that could make testing potential new treatments ...
The UCLA advance opens the door to growing other vascularized organ models, including intestines and colons, providing ...
Nutrition scientists have been working to understand the relationship between type 2 diabetes and genes that express a ...
A study published in Cell Stem Cell reveals that some mutations in blood stem cells might help protect against late-onset ...
This article makes a valuable contribution to the field by uncovering a molecular mechanism for miRNA intracellular retention, mediated by the interaction of PCBP2, SYNCRIP, and specific miRNA motifs.
Regeneron, playing catch up with J&J and Pfizer, wins FDA approval for Lynozyfic in multiple myeloma
Another BCMA-targeted agent has arrived for the treatment of multiple myeloma. | After a delay, Regeneron’s BCMA-directed ...
On Wednesday, Biokin reported (PDF) positive topline results from a phase 3 trial of the ADC. The study enrolled patients ...
Methods We developed three key reagents to evaluate VIP for SARS-CoV-2: (i) we engineered standard laboratory mice to express human ACE2 via rAAV9 in vivo gene transfer, to allow in vivo assessment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results